Revolution Medicines shares jump more than 35% after positive phase 3 pancreatic cancer trial

The move followed favorable late-stage results for daraxonrasib in metastatic pancreatic cancer, according to the source.

Summary

No Summary provided as the original text is short

Terms & Concepts
  • Phase 3 trial: A late-stage clinical study that tests a drug’s safety and effectiveness in a larger patient group before possible regulatory review.
  • Metastatic cancer: Cancer that has spread from its original site to other parts of the body, making treatment more complex.
  • Market capitalization: The total value of a company’s outstanding shares, often affected by large stock price moves after major news.